Share Search
Visit the Share Search
Biopharma Cred. Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Standard | GAAP | GAAP | GAAP | GAAP | GAAP |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Turnover | 159.68 | 212.22 | 127.63 | 100.55 | 142.34 |
| Operating Profit / Loss | 132.40 | 176.39 | 108.73 | 79.67 | 113.82 |
| Net Interest | n/a | n/a | n/a | n/a | n/a |
| Pre Tax Profit | 132.40 | 176.39 | 108.73 | 79.67 | 113.82 |
| Post Tax Profit | 132.40 | 176.39 | 108.73 | 79.67 | 113.82 |
| Continuing EPS | |||||
| Earnings per Share (Basic) | n/a USX | n/a USX | n/a USX | n/a USX | n/a USX |
| Earnings per Share (Diluted) | n/a USX | n/a USX | n/a USX | n/a USX | n/a USX |
| Earnings per Share (Adjusted) | n/a USX | n/a USX | n/a USX | n/a USX | n/a USX |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 10.11 USX | 12.93 USX | 7.91 USX | 5.80 USX | 8.28 USX |
| Earnings per Share (Diluted) | 10.11 USX | 12.93 USX | 7.91 USX | 5.80 USX | 8.28 USX |
| Earnings per Share (Adjusted) | 10.11 USX | 12.93 USX | 7.91 USX | 5.80 USX | 8.28 USX |
| Dividend per Share | 0.07 USD | 0.10 USD | 0.07 USD | 0.07 USD | 0.07 USD |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Non-Current Assets | |||||
| Intangible Assets | n/a | n/a | n/a | n/a | n/a |
| Tangible Assets | n/a | n/a | n/a | n/a | n/a |
| Fixed Investments | 1,201.36 | 1,223.65 | 1.27 | 1,194.83 | 1,116.13 |
| Total Fixed Assets | 1,201.36 | 1,223.65 | 1.27 | 1,194.83 | 1,116.13 |
| Current Assets | |||||
| Stocks | n/a | n/a | n/a | n/a | n/a |
| Debtors | 20.32 | 19.84 | 0.01 | 0.21 | 16.21 |
| Cash at Bank and in Hand | 135.05 | 120.53 | 0.09 | 193.27 | 296.64 |
| Total Assets | 1,356.73 | 1,364.02 | 1.37 | 1,388.31 | 1,428.97 |
| Current Liabilities | |||||
| Creditors Within 1Yr | 15.87 | 26.30 | 0.01 | 9.39 | 24.50 |
| Net Current Assets | 1,340.86 | 1,337.71 | 0.09 | 184.08 | 288.34 |
| Non-Current Liabilities | |||||
| Creditors After 1Yr | n/a | n/a | n/a | n/a | n/a |
| Net Assets | 1,340.86 | 1,337.45 | 1.36 | 1,378.92 | 1,403.74 |
| Capital and Reserves | |||||
| Called Up Share Capital | 13.74 | 13.74 | 0.01 | 13.74 | 13.74 |
| Share Premium Account | 607.12 | 607.12 | 0.61 | 607.12 | 607.12 |
| Other Reserves | 633.47 | 672.69 | 0.72 | 750.51 | 741.18 |
| Shareholders Funds | 1,340.86 | 1,337.45 | 1.36 | 1,378.92 | 1,403.74 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | |
| Operating Margin | 82.92% | 83.12% | 85.19% | 79.23% | 79.96% |
| Return on Capital Employed | 9.87% | 13.19% | 7,973.06% | 5.78% | 8.11% |
| Dividend Cover | 1.44 | 1.85 | 1.13 | 0.83 | 1.18 |
| Dividend Yield | 8.30 | 7.40 | 7.20 | 7.00 | 6.90 |
| PE Ratio | 8.30 | 7.30 | 12.20 | 17.20 | 12.30 |
| PEG | n/a | 0.30 | n/a | n/a | 0.30 |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 1.10 USD | 1.10 USD | 0.00 USD | 1.13 USD | 1.15 USD |